Uri Ben-Or - 18 Mar 2026 Form 3 Insider Report for Scinai Immunotherapeutics Ltd. (SCNI)

Role
Director
Signature
/s/ Uri Ben-Or
Issuer symbol
SCNI
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 10:06:28 UTC
Previous filing
03 Jan 2023
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ben-Or Uri Director C/O SCINAI IMMUNOTHERAPEUTICS LTD., JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM, ISRAEL /s/ Uri Ben-Or 18 Mar 2026 0001793464

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SCNI Ordinary shares, no par value per share ("Ordinary Shares") 33,329,004 18 Mar 2026 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SCNI American Depositary Shares 18 Mar 2026 Ordinary Shares 2,519,344 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.
F2 Includes 4,425,004 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on January 25, 2024, of which 25% vested on the six-month anniversary thereof, 8.33% vested on the 12-month anniversary thereof, and 66.66% vest in two equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. Each RSU represents a contingent right to receive one Ordinary Share upon vesting.
F3 Includes 904,000 Ordinary Shares that are represented by RSUs that were granted on November 21, 2024, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates
F4 Includes 28,000,000 Ordinary Shares that are represented by RSUs that were granted on November 12, 2025, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.
F5 Represents 630 American Depositary Shares, which are convertible at any time into 2,519,344 Ordinary Shares, at the holder's election and have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney.